The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|December 2, 2001
- Pharmaceutical Technology-12-02-2001
- Volume 25
- Issue 12
A Comprehensive Approach to Pharmaceutical Engineering Training
A training program at Rutgers University combines the disciplines of engineering and pharmaceutics to provide a thorough educational experience in drug manufacturing.
Advertisement
Articles in this issue
almost 25 years ago
Bioterrorism Threat Shines Spotlight on Drug Manufacturingalmost 25 years ago
E-Sourcing: Internet Facilitates Flexible Collaborationalmost 25 years ago
International Employment Survey 2001almost 25 years ago
Outsourcing OutlookAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement